Changes in heart rate and rhythm after intramuscular succinylcholine with or without atropine in anesthetized

Anesthesia and Analgesia
|December 1, 1986
PubMed

Insights

Intramuscular succinylcholine, with or without atropine, is safe for young children undergoing light anesthesia. This study found no severe bradycardia, indicating its potential use in pediatric anesthesia.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Cardiovascular Physiology

Background:

  • Intramuscular drug administration is an alternative route for pediatric anesthesia.
  • Succinylcholine is a common neuromuscular blocking agent, but its effects on heart rate require careful consideration, especially in children.
  • Atropine is often used to counteract bradycardia associated with certain anesthetic agents or neuromuscular blockers.

Purpose of the Study:

  • To investigate the effects of intramuscular succinylcholine, with or without atropine, on heart rate and rhythm in young children.
  • To determine the safety and efficacy of this administration route for succinylcholine in pediatric anesthesia.
  • To compare the cardiovascular effects of different doses of atropine when combined with succinylcholine.

Main Methods:

  • Fifty unpremedicated children aged 6-18 months received anesthesia induced with nitrous oxide-oxygen and halothane.
  • Study drugs (succinylcholine, atropine, or combinations) were administered intramuscularly 60 seconds after induction.
  • Heart rate and rhythm were monitored throughout the procedure, with comparisons made between groups and a control group.

Main Results:

  • Intramuscular succinylcholine (4 mg/kg) with or without atropine (0.02 mg/kg) caused transient increases in heart rate, followed by decreases, but not severe bradycardia.
  • A higher dose of atropine (0.03 mg/kg) with succinylcholine resulted in a prolonged secondary increase in heart rate.
  • Control patients experienced a decrease in heart rate after anesthetic induction.

Conclusions:

  • Intramuscular succinylcholine at 4 mg/kg can be safely administered to lightly anesthetized young children, with or without atropine (0.02 mg/kg), without causing significant bradycardia.
  • This route of administration offers a viable option for neuromuscular blockade in pediatric patients.
  • The findings support the use of intramuscular succinylcholine in specific pediatric anesthesia scenarios.

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...